False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.
作者信息
De Ravin Suk See, Gray John T, Throm Robert E, Spindler Jon, Kearney Mary, Wu Xiaolin, Coffin John M, Hughes Stephen H, Malderelli Frank, Sorrentino Brian P, Malech Harry L
机构信息
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
St Jude Children's Research Hospital, Memphis, Tennessee, USA.
出版信息
Mol Ther. 2014 Feb;22(2):244-245. doi: 10.1038/mt.2013.296.
Abstract
摘要
相似文献
1
False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.
Mol Ther. 2014 Feb;22(2):244-245. doi: 10.1038/mt.2013.296.
2
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
Sci Transl Med. 2016 Apr 20;8(335):335ra57. doi: 10.1126/scitranslmed.aad8856.
3
Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
Hum Gene Ther Methods. 2012 Oct;23(5):297-308. doi: 10.1089/hgtb.2012.150. Epub 2012 Nov 7.
4
Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression.
Mol Ther. 2010 May;18(5):965-76. doi: 10.1038/mt.2010.50. Epub 2010 Mar 30.
5
Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems.
Hum Gene Ther Methods. 2015 Feb;26(1):4-12. doi: 10.1089/hgtb.2014.122. Epub 2015 Feb 5.
6
Promoter competition for gene therapy of SCID-X1.
Hum Gene Ther. 2011 Mar;22(3):255-6. doi: 10.1089/hum.2011.2280.
7
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):527-34. doi: 10.1097/ACI.0000000000000114.
8
Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years.
J Biomed Sci. 2022 Oct 9;29(1):79. doi: 10.1186/s12929-022-00865-4.
9
Trial watch: Self-inactivating gene-therapy vector alleviates safety concerns.
Nat Rev Drug Discov. 2014 Dec;13(12):879. doi: 10.1038/nrd4495. Epub 2014 Nov 14.
10
Site-specific gene insertion mediated by a Cre-loxP-carrying lentiviral vector.
Mol Ther. 2010 Oct;18(10):1814-21. doi: 10.1038/mt.2010.150. Epub 2010 Jul 13.
引用本文的文献
1
False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma.
Bone Marrow Transplant. 2024 Aug;59(8):1190-1192. doi: 10.1038/s41409-024-02307-1. Epub 2024 May 17.
2
Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia.
Blood Adv. 2021 Jul 13;5(13):2701-2706. doi: 10.1182/bloodadvances.2020003680.
3
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.
Clin Case Rep. 2020 May 28;8(9):1678-1681. doi: 10.1002/ccr3.2918. eCollection 2020 Sep.
4
False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy.
J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.01420-19.
5
Myths in the laboratory diagnosis of HIV infection.
Emerg Microbes Infect. 2019;8(1):1240-1242. doi: 10.1080/22221751.2019.1656550.
6
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy.
Blood. 2018 Jun 7;131(23):2596-2598. doi: 10.1182/blood-2017-12-822940. Epub 2018 Apr 18.
7
False-positive HIV nucleic acid amplification testing during CAR T-cell therapy.
Diagn Microbiol Infect Dis. 2017 Aug;88(4):305-307. doi: 10.1016/j.diagmicrobio.2017.05.016. Epub 2017 Jun 3.
8
Gene Therapy for the Treatment of Primary Immune Deficiencies.
Curr Allergy Asthma Rep. 2016 May;16(5):39. doi: 10.1007/s11882-016-0615-8.
9
Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
Hum Gene Ther. 2016 Feb;27(2):108-16. doi: 10.1089/hum.2015.137.
10
Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.
Gene Ther. 2016 Feb;23(2):144-50. doi: 10.1038/gt.2015.101. Epub 2015 Oct 21.
本文引用的文献
1
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
Science. 2013 Aug 23;341(6148):1233158. doi: 10.1126/science.1233158. Epub 2013 Jul 11.
2
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
Science. 2013 Aug 23;341(6148):1233151. doi: 10.1126/science.1233151. Epub 2013 Jul 11.
3
Tracking replication-competent HIV reservoirs in infected individuals.
Curr Opin HIV AIDS. 2013 Mar;8(2):111-6. doi: 10.1097/COH.0b013e32835d6e1c.
4
Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
Hum Gene Ther Methods. 2012 Oct;23(5):297-308. doi: 10.1089/hgtb.2012.150. Epub 2012 Nov 7.
5
Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
J Virol. 2012 May;86(10):5719-29. doi: 10.1128/JVI.06300-11. Epub 2012 Mar 7.
6
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
7
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.
J Allergy Clin Immunol. 2011 Jun;127(6):1319-26; quiz 1327-8. doi: 10.1016/j.jaci.2011.03.028. Epub 2011 Apr 17.
8
Replication-competent lentivirus analysis of clinical grade vector products.
Mol Ther. 2011 Mar;19(3):557-66. doi: 10.1038/mt.2010.278. Epub 2010 Dec 21.
9
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.
Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931.
10
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.
Blood. 2010 Aug 12;116(6):900-8. doi: 10.1182/blood-2009-10-250209. Epub 2010 May 10.
Zotero 插件